10 research outputs found
A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast
A.D.R. performed the majority of the bioinformatic analysis and interpretation of the data. S.P. contributed to the study design, sample processing, analysis and interpretation of the data. J.S. contributed to the sample processing. D.J.K. and P.H. contributed to the data processing, batch correction and cell cluster identification. A.S. contributed to the design of the sample batches and contributed to the analysis of the raw data. A.J.T. contributed to the analysis of the data and Figure design. L.J.P. performed the immune histochemistry validations. K.H. assisted A.D.R. with the inferCNV analysis and interpretation. P.H. assisted with the subclustering of immune cells and scVI integration analysis. A.Q.S. performed the immunofluorescence quantification. K.K. performed all the scRNA-seq library preparation and sequencing. R.B.M., I.G., J.J.G., V.S. and J.L.J. provided the human tissues and the metadata from the 55 donors. A.D.R., S.P., J.C.M. and W.T.K. wrote the paper. J.C.M. and W.T.K. conceptualized and supervised the study.Peer reviewe
Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3
MGB-BP-3 is a potential first-in-class antibiotic, a Strathclyde Minor Groove Binder (S-MGB), that has successfully completed Phase IIa clinical trials for the treatment of Clostridioides difficile associated disease. Its precise mechanism of action and the origin of limited activity against Gram-negative pathogens are relatively unknown. Herein, treatment with MGB-BP-3 alone significantly inhibited the bacterial growth of the Gram-positive, but not Gram-negative, bacteria as expected. Synergy assays revealed that inefficient intracellular accumulation, through both permeation and efflux, is the likely reason for lack of Gram-negative activity. MGB-BP-3 has strong interactions with its intracellular target, DNA, in both Gram-negative and Gram-positive bacteria, revealed through ultravioletāvisible (UVāvis) thermal melting and fluorescence intercalator displacement assays. MGB-BP-3 was confirmed to bind to dsDNA as a dimer using nano-electrospray ionization mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. Type II bacterial topoisomerase inhibition assays revealed that MGB-BP-3 was able to interfere with the supercoiling action of gyrase and the relaxation and decatenation actions of topoisomerase IV of both Staphylococcus aureus and Escherichia coli. However, no evidence of stabilization of the cleavage complexes was observed, such as for fluoroquinolones, confirmed by a lack of induction of DSBs and the SOS response in E. coli reporter strains. These results highlight additional mechanisms of action of MGB-BP-3, including interference of the action of type II bacterial topoisomerases. While MGB-BP-3ā²s lack of Gram-negative activity was confirmed, and an understanding of this presented, the recognition that MGB-BP-3 can target DNA of Gram-negative organisms will enable further iterations of design to achieve a Gram-negative active S-MGB
Recommended from our members
A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast.
Acknowledgements: We thank the staff at the Cambridge NIHR BRC Cell Phenotyping Hub and the Genomic and Histopathology Core at the CRUK Cambridge Institute for their constant support and assistance and S. Westermann for designing the schematic in Fig. 1. We acknowledge the role of the Breast Cancer Now Tissue Bank in collecting and making available the samples used in the generation of this publication and all the patients who donated. This study was primarily funded by an MRC project grant (MR/S036059/1) and supported by BBSRC project grant (BB/S006745/1), Breast Cancer Now project grant (2017MayPR907), CRUK career establishment award (17348) and CRUK programme foundation award (DCRPGF\100010) to W.T.K. and core funding from EMBL and CRUK (C9545/A29580) to J.C.M.Here we use single-cell RNA sequencing to compile a human breast cell atlas assembled from 55 donors that had undergone reduction mammoplasties or risk reduction mastectomies. From more than 800,000 cells we identified 41 cell subclusters across the epithelial, immune and stromal compartments. The contribution of these different clusters varied according to the natural history of the tissue. Age, parity and germline mutations, known to modulate the risk of developing breast cancer, affected the homeostatic cellular state of the breast in different ways. We found that immune cells from BRCA1 or BRCA2 carriers had a distinct gene expression signature indicative of potential immune exhaustion, which was validated by immunohistochemistry. This suggests that immune-escape mechanisms could manifest in non-cancerous tissues very early during tumor initiation. This atlas is a rich resource that can be used to inform novel approaches for early detection and prevention of breast cancer.This study was primarily funded by an MRC project grant (MR/S036059/1), CRUK career establishment award (17348) and CRUK programme foundation award (DCRPGF\100010) to WTK and core funding from EMBL and CRUK (C9545/A29580) to JCM
Recommended from our members
A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast.
Here we use single-cell RNA sequencing to compile a human breast cell atlas assembled from 55 donors that had undergone reduction mammoplasties or risk reduction mastectomies. From more than 800,000 cells we identified 41 cell subclusters across the epithelial, immune and stromal compartments. The contribution of these different clusters varied according to the natural history of the tissue. Age, parity and germline mutations, known to modulate the risk of developing breast cancer, affected the homeostatic cellular state of the breast in different ways. We found that immune cells from BRCA1 or BRCA2 carriers had a distinct gene expression signature indicative of potential immune exhaustion, which was validated by immunohistochemistry. This suggests that immune-escape mechanisms could manifest in non-cancerous tissues very early during tumor initiation. This atlas is a rich resource that can be used to inform novel approaches for early detection and prevention of breast cancer.This study was primarily funded by an MRC project grant (MR/S036059/1), CRUK career establishment award (17348) and CRUK programme foundation award (DCRPGF\100010) to WTK and core funding from EMBL and CRUK (C9545/A29580) to JCM
Insights into the Spectrum of Activity and Mechanism of Action of MGB-BPā3
MGB-BP-3
is a potential first-in-class antibiotic, a Strathclyde
Minor Groove Binder (S-MGB), that has successfully completed Phase
IIa clinical trials for the treatment of Clostridioides
difficile associated disease. Its precise mechanism
of action and the origin of limited activity against Gram-negative
pathogens are relatively unknown. Herein, treatment with MGB-BP-3
alone significantly inhibited the bacterial growth of the Gram-positive,
but not Gram-negative, bacteria as expected. Synergy assays revealed
that inefficient intracellular accumulation, through both permeation
and efflux, is the likely reason for lack of Gram-negative activity.
MGB-BP-3 has strong interactions with its intracellular target, DNA,
in both Gram-negative and Gram-positive bacteria, revealed through
ultravioletāvisible (UVāvis) thermal melting and fluorescence
intercalator displacement assays. MGB-BP-3 was confirmed to bind to
dsDNA as a dimer using nano-electrospray ionization mass spectrometry
and nuclear magnetic resonance (NMR) spectroscopy. Type II bacterial
topoisomerase inhibition assays revealed that MGB-BP-3 was able to
interfere with the supercoiling action of gyrase and the relaxation
and decatenation actions of topoisomerase IV of both Staphylococcus aureus and Escherichia
coli. However, no evidence of stabilization of the
cleavage complexes was observed, such as for fluoroquinolones, confirmed
by a lack of induction of DSBs and the SOS response in E. coli reporter strains. These results highlight
additional mechanisms of action of MGB-BP-3, including interference
of the action of type II bacterial topoisomerases. While MGB-BP-3ā²s
lack of Gram-negative activity was confirmed, and an understanding
of this presented, the recognition that MGB-BP-3 can target DNA of
Gram-negative organisms will enable further iterations of design to
achieve a Gram-negative active S-MGB
Ć-Detected NMR of āøLiāŗ in Bi, Sb, and the topological insulator Biā.ā Sbā.ā
We report the NMR Knight shift and spin-lattice relaxation of 8Li+ implanted ~100 nm into single crystals of semimetallic Sb, Bi, and topologically insulating Bi0.9Sb0.1. We find small negative shifts (of order 100 ppm) in all three. In the insulator, the shift is nearly temperature independent, while in Bi and Sb it becomes more negative at low temperature without following the bulk susceptibility, suggesting two distinct temperature dependent contributions, possibly from the orbital and spin response. However, a simple model is unable to account for the observed shift. The spin-lattice relaxation differs in both scale and temperature dependence in all three. It is Korringa-like in Bi and remarkably is fastest in the insulating alloy and slowest in Sb with the highest bulk carrier density. These surprising results call for detailed calculations, but phenomenologically demonstrate that Ī²-detected NMR of implanted 8Li+ is sensitive to the magnetic response of low-density carriers. The prospects for depth-resolved studies of conventional and topological surface states at lower implantation energies are good
Ī±-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors
OBJECTIVE: Central melanocortin pathways are well-established regulators of energy balance. However, scant data exist about the role of systemic melanocortin peptides. We set out to determine if peripheral α-melanocyte stimulating hormone (α-MSH) plays a role in glucose homeostasis and tested the hypothesis that the pituitary is able to sense a physiological increase in circulating glucose and responds by secreting α-MSH. METHODS: We established glucose-stimulated α-MSH secretion using humans, non-human primates, and mouse models. Continuous α-MSH infusions were performed during glucose tolerance tests and hyperinsulinemic-euglycemic clamps to evaluate the systemic effect of α-MSH in glucose regulation. Complementary ex vivo and in vitro techniques were employed to delineate the direct action of α-MSH via the melanocortin 5 receptor (MC5R)-PKA axis in skeletal muscles. Combined treatment of non-selective/selective phosphodiesterase inhibitor and α-MSH was adopted to restore glucose tolerance in obese mice. RESULTS: Here we demonstrate that pituitary secretion of α-MSH is increased by glucose. Peripheral α-MSH increases temperature in skeletal muscles, acts directly on soleus and gastrocnemius muscles to significantly increase glucose uptake, and enhances whole-body glucose clearance via the activation of muscle MC5R and protein kinase A. These actions are absent in obese mice, accompanied by a blunting of α-MSH-induced cAMP levels in skeletal muscles of obese mice. Both selective and non-selective phosphodiesterase inhibition restores α-MSH induced skeletal muscle glucose uptake and improves glucose disposal in obese mice. CONCLUSION: These data describe a novel endocrine circuit that modulates glucose homeostasis by pituitary α-MSH, which increases muscle glucose uptake and thermogenesis through the activation of a MC5R-PKA-pathway, which is disrupted in obesity